Why the study?
Does aortocoronary reoperation provide clinical benefit in patients with intractable angina following initial bypass surgery?
Does aortocoronary reoperation provide clinical benefit in patients with intractable angina following initial bypass surgery?
Aortocoronary reoperation carries a higher mortality risk than initial CABG but provides successful outcomes in 60-70% of survivors depending on the underlying coronary pathology.
Answers are grounded in this paper and cite their sources.
May benefit select post-CABG patients with intractable angina; leaves open optimal pathology-based selection in prospective trials.
There is an increasing incidence of aorto coronary reoperation necessitated by intractable angina which averages 2% of 4676 initial bypass procedures. Graft obliteration, graft stenosis or progression of disease led to recurrence of symptoms in 96 patients (84 male, 12 female) who underwent a second operation. Not all occluded or stenotic bypasses were feasible for reoperation. Hospital mortality (30 days) was higher than after initial CABG, but could be reduced from 12.1% to 4.8%. Subjective and objective follow-up investigations were obtained in 77 of 84 survivors and demonstrate that successful reoperation is about 10% lower in patients with a malignant form of atherosclerosis (60%) than in patients who only suffer from occluded grafts or new proximal significant stenoses in previously unbypassed vessels (70%).
No takes yet. Share an insight, caveat, or question.
Weinhold et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: